IRBESARTAN
- Product NDC
- 61919-793
- 11-digit product format
- 619190793
- Labeler code
- 61919
- Product ID
- 61919-793_85139b8a-69ff-72e7-e053-2a91aa0afd45
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- IRBESARTAN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DIRECTRX
- Application
- ANDA202254
- Marketing category
- ANDA
- Marketing start
- 2019-03-27
- Marketing end
- 0000-00-00
- Substance
- IRBESARTAN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-793-30 | 61919079330 | 30 TABLET in 1 BOTTLE (61919-793-30) | 30 tablet | 2019-03-27 | 0000-00-00 | No | No | Current |